Ivan P. Gergel, SVP & Chief Medical Officer at NEKTAR THERAPEUTICS (NKTR), sold 100,000 shares at $24.21 ($2.4M) on 2017-10-02, disclosed to the SEC on 2017-10-03.
Scheduled sale ($2.4M) by SVP & Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.04 | 43,296 | $1.0M | 43.1% |
| 2 | $24.21 | 56,704 | $1.4M | 56.9% |
| Total | $24.14 avg | 100,000 | $2.4M | 100% |
| Filing → |
| NKTR | SELL | 2017-07-13 | $1.9M | — | Filing → |
| NKTR | SELL | 2017-05-18 | $28K | — | Filing → |
| NKTR | SELL | 2017-02-17 | $19K | — | Filing → |